Direct evidence to support the immunosurveillance concept in a human regressive melanoma.
about
Conserved T cell receptor repertoire in primary and memory CD8 T cell responses to an acute viral infectionT-cell clonotypes in cancerTAP1 down-regulation in primary melanoma lesions: an independent marker of poor prognosis.Chronic alcohol consumption enhances myeloid-derived suppressor cells in B16BL6 melanoma-bearing mice.Immunotherapy: on the edge between experimental and clinical oncology.Cytotoxic T-lymphocyte clones from different patients display limited T-cell-receptor variable-region gene usage in HLA-A2-restricted recognition of the melanoma antigen Melan-A/MART-1.A phase-I clinical study of autologous tumor cells plus interleukin-2-gene-transfected allogeneic fibroblasts as a vaccine in patients with cancer.In vivo accumulation of the same anti-melanoma T cell clone in two different metastatic sites.Vaccination with IL-7 gene-modified autologous melanoma cells can enhance the anti-melanoma lytic activity in peripheral blood of patients with a good clinical performance status: a clinical phase I study.Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma.Immune suppression in tumors as a surmountable obstacle to clinical efficacy of cancer vaccinesLectin microarrays identify cell-specific and functionally significant cell surface glycan markers.Tumor-infiltrating lymphocytes: apparently good for melanoma patients. But why?Comparative assessment of TCRBV diversity in T lymphocytes present in blood, metastatic lesions, and DTH sites of two melanoma patients vaccinated with an IL-7 gene-modified autologous tumor cell vaccine.Characterization of MHC class-I restricted TCRalphabeta+ CD4- CD8- double negative T cells recognizing the gp100 antigen from a melanoma patient after gp100 vaccination.Improved assessment of T-cell receptor (TCR) VB repertoire in clinical specimens: combination of TCR-CDR3 spectratyping with flow cytometry-based TCR VB frequency analysis.Clonal T cell expansion induced by interleukin 2 therapy in blood and tumors.Clonal expansion of T lymphocytes in human melanoma metastases after treatment with a hapten-modified autologous tumor vaccine.Tumor suppressive efficacy through augmentation of tumor-infiltrating immune cells by intratumoral injection of chemokine-expressing adenoviral vector.Functional characterization of CD8(+) antigen-specific cytotoxic T lymphocytes after enrichment based on cytokine secretion: comparison with the MHC-tetramer technology.In situ demonstration of renal-cell-carcinoma-specific T-cell clones.The biologic importance of tumor-infiltrating lymphocytes.Malignant melanoma in an HIV-infected man: a case report and literature review.CD8(+) T cells in Hodgkin's disease tumor tissue are a polyclonal population with limited clonal expansion but little evidence of selection by antigen.Induction and clonal expansion of tumor-specific cytotoxic T lymphocytes from renal cell carcinoma patients after stimulation with autologous dendritic cells loaded with tumor cells.In vitro and in vivo characterization of graft-versus-tumor responses in melanoma patients after allogeneic peripheral blood stem cell transplantation.Altered T cell repertoire usage in CD4 and CD8 subsets of multiple myeloma patients, a Study of the Eastern Cooperative Oncology Group (E9487).Astrocytoma infiltrating lymphocytes include major T cell clonal expansions confined to the CD8 subset.Persistence of clonal T-cell expansions following high-dose chemotherapy and autologous peripheral blood progenitor cell rescue.In vivo selective expansion of a tumour-specific cytotoxic T-cell clone derived from peripheral blood of a melanoma patient after vaccination with gene-modified autologous tumour cells.Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients.T-cell analysis in identical twins reveals an impaired anti-follicular lymphoma immune response in the patient but not in the healthy twin
P2860
Q24657414-1222A6F9-47A2-4035-BAFA-7A0AF71A20C1Q24803891-8B3D2D06-31C3-4384-82AD-DD1697DDA07BQ32159956-6EA769DD-DB42-4792-A96D-B84F24B7076AQ33898612-48ACEDB6-56ED-4659-B966-26D6B50D2739Q34172095-81FF1E25-33DF-4F74-9FAA-03B47DA1D32CQ34247704-00F20AB6-1D21-43C0-AE47-2D872047C0B7Q34416464-2859187C-B36A-4117-BCB3-5B1DFE52D281Q35996832-6AC0BCB4-6513-40BE-BF19-17C06164CB93Q36292705-BAD02005-2CE5-41A6-815D-949C6CF8261BQ36639818-172000E8-82D2-428B-BB0B-781E7F929DC3Q37137360-30ED6ABF-34DC-457C-9802-75A60D626D9CQ37323215-D840465B-BB9D-4212-A7A6-64D04280A4E9Q37873379-642E1B80-1717-4732-999B-99B8B2098AF8Q38291127-6068FA0F-02A7-4146-8F46-D6CE5A7C741CQ39418029-E014215E-D045-4005-8581-F0C39FA84098Q39625498-0FF96A2E-E5F0-4509-9772-27CF81B11CC0Q39761568-E64C647F-FA43-419F-9C74-51BBF215EEA3Q39778695-60D98FCA-04F0-4053-8483-83A475C3A4B6Q40362146-D12C9A49-EA42-439E-A367-52885998006CQ40837162-4B417FB2-2152-4956-AEF0-DE8C17B83F2EQ41198239-B03779FF-5B5A-4508-992C-8742A1F8B0B6Q41897354-EF3EED45-8C67-4FE2-86C0-9BBDD3555CCAQ42455222-55D8F3ED-82A0-4FD4-AE02-BA62C3CB54F2Q42856838-CE395EBB-8FA7-46E1-A4B0-BB2D0C22D94EQ43557973-9B8C6FAB-FDD3-4048-A0A4-11D1E1C44ED9Q44124088-07912294-CA61-41EA-93F7-CF2376C3E005Q44859474-FA558C4F-CE58-4647-A7E5-8A7AE25E5DB1Q48152277-FB3EBF1D-781D-4252-AF86-45CE671D9F99Q52863319-B3137E3D-0DB3-4ED4-B17B-B294D0351E4DQ53437611-A17A0C07-B3C4-4587-ACEB-163D425AB719Q54977188-A3875E6D-AB51-4D8E-8140-319DFBCD8B99Q57556514-776B6937-2BDA-4B26-B449-B6F05F90F5C6
P2860
Direct evidence to support the immunosurveillance concept in a human regressive melanoma.
description
1994 nî lūn-bûn
@nan
1994 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Direct evidence to support the immunosurveillance concept in a human regressive melanoma.
@ast
Direct evidence to support the immunosurveillance concept in a human regressive melanoma.
@en
Direct evidence to support the immunosurveillance concept in a human regressive melanoma.
@nl
type
label
Direct evidence to support the immunosurveillance concept in a human regressive melanoma.
@ast
Direct evidence to support the immunosurveillance concept in a human regressive melanoma.
@en
Direct evidence to support the immunosurveillance concept in a human regressive melanoma.
@nl
prefLabel
Direct evidence to support the immunosurveillance concept in a human regressive melanoma.
@ast
Direct evidence to support the immunosurveillance concept in a human regressive melanoma.
@en
Direct evidence to support the immunosurveillance concept in a human regressive melanoma.
@nl
P2093
P2860
P356
P1476
Direct evidence to support the immunosurveillance concept in a human regressive melanoma.
@en
P2093
Carcelain G
Mackensen A
Michalaki H
P2860
P304
P356
10.1172/JCI117116
P407
P577
1994-04-01T00:00:00Z